Evidence map›Paper›PMID 34403775›Full record

ArticleJournal of virological methods2021

The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 "doublethink" effect.

Alessandro Manenti, Eleonora Molesti, Marta Maggetti, Alessandro Torelli, Giulia Lapini, Emanuele Montomoli

Open access · hybridAbstract read
In one paragraph

Article in Journal of virological methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alessandro ManentiVisMederi s.r.l., Siena, Italy. Electronic address: alessandro.manenti@vismederi.com.
Eleonora MolestiVisMederi Research s.r.l., Siena, Italy.
Marta MaggettiVisMederi s.r.l., Siena, Italy.
Alessandro TorelliVisMederi s.r.l., Siena, Italy.
Giulia LapiniVisMederi s.r.l., Siena, Italy.
Emanuele MontomoliVisMederi s.r.l., Siena, Italy; VisMederi Research s.r.l., Siena, Italy; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
VisMederi Research · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neutralization assays are considered the gold-standard being capable of evaluating and detecting, functional antibodies. To date, many different protocols exist for micro-neutralization (MN) assay which varies in several steps: cell number and seeding conditions, virus amount used in the infection step, virus-serum-cells incubation time and read out. The aim of the present preliminary study was to carry out SARS-CoV-2 wild type MN assay in order to investigate which optimal tissue culture infective dose 50 (TCID

Indexed as

COVID-19SARS-CoV-2Antibodies, NeutralizingAntibodies, ViralHumansNeutralization TestsReproducibility of ResultsAntibodies, NeutralizingAntibodies, ViralImmunological responsesInfective doseLive virusMicro-neutralisationSARS-CoV-2

Identifiers

PMID34403775
PMCPMC8364219
OpenAlexW3193565140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.